ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

Obituary: Michale Keeling, of M.D. Anderson.

January 2, 2004

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Bioassay Report Clears EDTA

August 12, 1977

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013